 |
|
 |
 |
 |
|
 |
 |
Joshua A. Hirsch, MD, FSIR Raul G. Nogueira, MD Johnny C. Pryor, MD James D. Rabinov, MD Albert J. Yoo, MD Christopher S. Ogilvy, MD Teresa Vander Boom, RN - Nurse Coordinator Marion Growney, Nurse Practitioner Interventional Neuroradiology - Technologists & RN 2006-2007 Radiology Fellows - ( Download PDF )  Joshua A. Hirsch, MD, FSIRDr. Hirsch earned his medical degree from the University of Pennsylvania School of Medicine. After completing an internship in medicine at Pennsylvania Hospital and a residency/fellowship in Radiology/Neuroradiology at the Hospital of the University of Pennsylvania, he served as fellow in Interventional Neuroradiology at the Neurovascular Center of the Lahey Medical Center. He has worked on the staff at the Lahey Clinic and then at the Beth Israel Deaconess Medical Center in Boston. In 2003 Dr. Hirsch joined the Massachusetts General Hospital and is the Director of Interventional Neuroradiology and Endovascular Neurosurgery. He is an Assistant Professor at Harvard Medical School. He is a senior member of the American Society of Neuroradiology and the Society of Neurointerventional Surgery (SNIS). Recently, Dr. Hirsch has been asked to help draft the Practice Guidelines for Neurointerventionalists of the American College of Radiology. Dr. Hirsch has extensive experience in the diagnosis, management and treatment of cerebrovascular disease. This includes the treatment of aneurysms, arteriovenous malformations, dural arteriovenous fistulas, pre-operative embolization of tumors and treatment of head and neck lesions including epistaxis. Another part of the specialty is that of stroke prevention which includes carotid and vertebral artery angioplasty and stenting as well as acute stroke treatment with thrombolysis. Considered expert in minimally invasive spine surgery Dr. Hirsch has lectured and instructed physicians in the vertebroplasty and kyphoplasty for the treatment of compression fractures. Dr. Hirsch also uses percutaneous nucleoplasty using the DeKompressor technique and the IDET procedure. Dr. Hirsch has brought the ACTIVE prospective vertebroplasty trial to MGH and will serve as the institutional principal investigator. He is also actively involved in the upcoming NIH prospective vertebroplasty trial.  Raul G. Nogueira, MDDr. Nogueira completed medical school at the Federal University of Ceara in Brazil. He is fully trained in Internal Medicine and Neurology. Dr. Nogueira came to the Massachusetts General Hospital in 1999 where he completed his neurology residency and then fellowships in Neurocritical Care/Stroke, and Diagnostic and Interventional Neuroradiology. Dr. Nogueira is an Instructor at Harvard Medical School. He is member of the American Academy of Neurology, American Stroke Association, and the Society of Neurointerventional Surgery (SNIS). Dr. Nogueira was one of the founders of the Society of Vascular and Interventional Neurology. Dr. Nogueira has extensive experience in the diagnosis, management, and treatment of neurovascular diseases including brain aneurysms, arteriovenous malformations, dural arteriovenous fistulas, pre-operative embolization of tumors and treatment of head and neck lesions including epistaxis. Another part of the specialty is that of stroke prevention which includes carotid and vertebral artery angioplasty and stenting as well as acute stroke treatment with thrombolysis. Dr. Nogueira is the MGH Principal Investigator in the NIH-funded Interventional Management of Stroke Phase III Trial, the largest study ever performed to evaluate the results of catheter-based stroke treatment. He is also currently involved in many clinical research projects involving cerebral aneurysms and subarachnoid hemorrhage, vasospasm, cerebral blood flow and oxygenation measurements, and the treatment of stroke with angioplasty and stenting.  Johnny C. Pryor, MDDr. Pryor completed his medical school training at the University of Mississippi and his Neurosurgical residency at Washington University in St. Louis. He completed his Interventional Neuroradiology fellowship training at NYU and was on the staff at Beth Israel North for several years. He has been at Massachusetts General Hospital since 2001. He is Board certified in Neurosurgery. He is a member of the AANS and the Society of Neurointerventional Surgery (SNIS). Dr. Pryor is an Instructor at Harvard Medical School. Dr. Pryor has extensive experience in the diagnosis, management and treatment of cerebrovascular disease. This includes the treatment of aneurysms, arteriovenous malformations, dural arteriovenous fistulas, pre-operative embolization of tumors and treatment of head and neck lesions including epistaxis. Another part of the specialty is that of stroke prevention which includes carotid and vertebral artery angioplasty and stenting as well as acute stroke treatment with thrombolysis. Dr. Pryor is the Primary Investigator in the ONYX AVM Trial and Phase I Trials of the Concentric clot retrieval device (MERCI). He introduced intra-arterial Nicardipine for the treatment of vasospasm following subarachnoid hemorrhage. He is currently involved in basic research on endothelial cell activity for in-vivo treatment of neurovascular disorders and animal stroke models.  James D. Rabinov, MDDr. Rabinov completed medical school and Radiology residency at Boston University Medical Center. He has completed fellowships in Diagnostic Neuroradiology and Interventional Neuroradiology at Massachusetts General Hospital. Also, he completed an ENT Radiology fellowship at Massachusetts Eye and Ear Infirmary and remains a member of their staff. Dr. Rabinov is an Assistant Professor at Harvard Medical School and the Fellowship Director in Interventional Neuroradiology and Endovascular Neurosurgery at MGH. He holds staff appointments in both Neuroradiology and Neurosurgery at MGH. He is a member of the American College of Radiology, the American Society of Neuroradiology, and the Society of Neurointerventional Surgery (SNIS). Dr. Rabinov has extensive experience in the diagnosis, management and treatment of cerebrovascular disease. This includes the treatment of aneurysms, arteriovenous malformations, dural arteriovenous fistulas, pre-operative embolization of tumors and treatment of head and neck lesions including epistaxis. Another part of the specialty is that of stroke prevention which includes carotid and vertebral artery angioplasty and stenting as well as acute stroke treatment with thrombolysis. He is the primary investigator for a protocol using the Neuroform Stent system to aid in the treatment of complex aneurysms. He has helped to pioneer the technique of CT angiography for the work up and treatment planning of Neurovascular diseases. This has changed the treatment algorithm of acutely ill patients with subarachnoid hemorrhage, acute stroke and venous occlusive disease. He has recently published a 10 year experience in the diagnosis and treatment of dissecting aneurysms of the vertebrobasilar system. With Dr. Pryor he defined the protocol and dosage scheme for intra-arterial Nicardipine for the treatment of vasospasm following subarachnoid hemorrhage. His facility with MRI technology brings a solid research foundation as the section begins to utilize their combined angiography and MRI suite. Dr. Rabinov is responsible for the design and content of this web site.  Albert J. Yoo, MDDr. Yoo earned his medical degree from Washington University in St. Louis. He completed an internship in medicine at Brigham and Women’s Hospital, followed by a residency in radiology at Massachusetts General Hospital. He went on to complete a fellowship in Interventional Neuroradiology, also at Massachusetts General Hospital. Dr. Yoo is an Instructor at Harvard Medical School. He is a member of the American Society of Neuroradiology and the Society of Neurointerventional Surgery (SNIS). Dr. Yoo has extensive experience in the diagnosis, management and treatment of cerebrovascular disease. This includes the treatment of aneurysms, arteriovenous malformations, dural arteriovenous fistulas, pre-operative embolization of tumors and treatment of head and neck lesions including epistaxis. Another part of the specialty is that of stroke prevention which includes carotid and vertebral artery angioplasty and stenting as well as acute stroke treatment with thrombolysis. Dr. Yoo is involved in the minimally invasive spine surgery practice, which includes the use of vertebroplasty and kyphoplasty for the treatment of both benign and malignant compression fractures. Dr. Yoo is involved in clinical research projects studying the imaging and intra-arterial management of acute ischemic stroke. He received the 2006-7 NER Foundation/Boston Scientific Fellowship in Cerebrovascular Disease Research. Dr. Yoo also has research interests in vertebral augmentation, particularly in the setting of malignant fractures.  Christopher S. Ogilvy, MDChristopher S. Ogilvy, MD, is Director of Endovascular and Operative Neurovascular Surgery and the Robert G. and A. Jean Ojemann Professor of Neurosurgery at Massachusetts General Hospital. Dr. Ogilvy is also the Director of The Brain Aneurysm/Arteriovenous Malformation (AVM) Center at Massachusetts General Hospital and is a member of the Mass General Vascular Center. Dr Oglivy earned his medical degree from Dartmouth Medical School in 1984. He completed an internship in general surgery at Columbia Presbyterian Medical Center in 1985 and served his residency at Massachusetts General Hospital from 1985 to 1991. He completed a fellowship in endovascular neurosurgery at the University of Buffalo in 2009. Dr. Oglivy's specialties include endovascular neurosurgery and operative microneurosurgery. His clinical interests include cerebral aneurysm, cerebral/spinal AVM, cavernous malformation, acute stroke, carotid disease, Moya-Moya disease, and intra-arterial and vertebrobasilar atherosclerotic disease.
Interventional Neuroradiology - Technologists & RN  Back row: Mark Shrewsbury Front row: Nelson Orr, Joe DiBenedetto, Elizabeth Ingraham, RN
|
 |
||||
 |
||||||
